These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9554533)

  • 1. Mitosis identification in diffuse gliomas: implications for tumor grading.
    Coons SW; Pearl DK
    Cancer; 1998 Apr; 82(8):1550-5. PubMed ID: 9554533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
    Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
    Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy in supratentorial gliomas. A study of 821 cases.
    Heesters M; Molenaar W; Go GK
    Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas.
    Yamaguchi S; Kobayashi H; Terasaka S; Ishii N; Ikeda J; Kanno H; Nishihara H; Tanaka S; Houkin K
    Jpn J Clin Oncol; 2012 Apr; 42(4):270-7. PubMed ID: 22399670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate?
    Muragaki Y; Chernov M; Maruyama T; Ochiai T; Taira T; Kubo O; Nakamura R; Iseki H; Hori T; Takakura K
    Minim Invasive Neurosurg; 2008 Oct; 51(5):275-9. PubMed ID: 18855292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendrogliomas.
    Coons SW; Johnson PC; Pearl DK; Olafsen AG
    Neurosurgery; 1994 Apr; 34(4):680-7; discussion 687. PubMed ID: 8008167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
    Prayson RA; Mohan DS; Song P; Suh JH
    Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histological classification of human gliomas: state of art and controversies].
    Figarella-Branger D; Bouvier C
    Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice].
    Fontaine D; Vandenbos F; Lebrun C; Paquis V; Frenay M
    Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of malignant features in oligodendroglial tumors.
    Saito A; Nakazato Y
    Clin Neuropathol; 1999; 18(2):61-73. PubMed ID: 10192700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 in oligodendroglial neoplasms.
    Castilla EA; Prayson RA; Kanner AA; Rybicki LA; Tubbs RR; Vogelbaum MA; Barnett GH
    Cancer; 2003 Oct; 98(7):1465-72. PubMed ID: 14508834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
    Okamoto Y; Di Patre PL; Burkhard C; Horstmann S; Jourde B; Fahey M; Schüler D; Probst-Hensch NM; Yasargil MG; Yonekawa Y; Lütolf UM; Kleihues P; Ohgaki H
    Acta Neuropathol; 2004 Jul; 108(1):49-56. PubMed ID: 15118874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological grading of gliomas.
    Daumas-Duport C
    Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):924-31. PubMed ID: 1334739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.
    Miller CR; Dunham CP; Scheithauer BW; Perry A
    J Clin Oncol; 2006 Dec; 24(34):5419-26. PubMed ID: 17135643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathology of malignant gliomas.
    Bruner JM
    Semin Oncol; 1994 Apr; 21(2):126-38. PubMed ID: 8153659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Grading of astrocytomas and oligodendrogliomas].
    Kolles H; Niedermayer I; Feiden W
    Pathologe; 1998 Jul; 19(4):259-68. PubMed ID: 9746910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.
    Gupta M; Djalilvand A; Brat DJ
    Am J Clin Pathol; 2005 Nov; 124(5):755-68. PubMed ID: 16203285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.